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Background and aims: High plasma levels of the sphingolipid metabolism intermediates 
ceramide (Cer) and sphingosine-1-phosphate (S1P) have been found in obese and type 2 diabetic 
patients. Cer and S1P are reported to induce the inflammatory response leading to impaired insulin 
signaling in peripheral tissues. Emerging evidence suggests that accumulating Advanced Glycation 
End-products (AGEs) can alter the sphingolipids metabolism equilibrium. We, thus, investigated 
whether AGEs accumulation can affect the sphingolipids metabolism in animal models of insulin 
resistance. 
Materials and methods: To study the direct contribution of AGEs to sphingolipids metabolism and 
the putative role of the AGE-receptor RAGE therein, HepG2 cells were incubated with 0.5 μM 
control-albumin and modified N-carboxymethyllysine (CML)-albumin, pre-incubated or not with 
RAGE antibody. To study the role of AGEs on in vivo sphingolipid metabolism, C57Bl/6J (WT), and 
LeptrDb-/- (DbDb) mice were fed a standard diet (SD), while a group of C57Bl/6J was fed a 60% 
trans-fat diet (HFD). Two subgroups of SD and HFD mice were supplemented with the anti-AGEs 
compound pyridoxamine. AGEs levels were evaluated in the liver by LC-MSMS and Cer and S1P 
by GC-MS. The expressions of RAGE and of the enzymes involved in sphingolipid metabolism 
were assessed by RT-PCR and western blotting. 
Results: High levels of AGEs and RAGE were detected in the liver of both DbDb and HFD mice in 
comparison to WT controls. Moreover, the expression of the sphingolipid metabolism enzymes 
ceramide synthase 2 and 5 and sphingosine kinase 1 was increased, while those of neutral 
ceramidase and S1P phosphatase was reduced, accompanied by increased levels of Cer and 
S1P. In addition, pyridoxamine supplementation to HFD mice diminished hepatic AGEs 
accumulation and prevented sphingolipids metabolism and insulin signaling alterations. In line, 
CML administration to HepG2 cells evoked alterations similar to those observed in vivo, and 
blocking antibodies against RAGE reverted some of the altered enzyme expressions.  
Conclusion: The sphingolipid metabolism is affected in different models of diabetes. The 
modulation of the enzymes responsible for maintenance of the sphingolipid metabolism equilibrium 
in CML-incubated HepG2 cells indicate the direct involvement of AGEs and their receptor RAGE. 
The role of AGEs was confirmed by the in vivo action of pyridoxamine. These results suggest that 
the modulation of sphingolipids metabolism through the prevention of AGEs accumulation may 
reduce insulin resistance development.  
